Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06926725

Effect of High Intensity Interval Training and Ultrasound Cavitation on Lipid Profile in Type 2 Diabetes Patients

The study aim to find out the combined effect of high intensity interval training and ultrasound cavitation on lipid profile in type two diabetic patient with abdominal obesity.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

30 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beni-Suif University Hospital

GIZA, Cairo Governorate, 11865, Egypt

Location contact

Sara El-din

CONTACT

About this study

study aim to find out the combined effect of high intensity interval training and ultrasound cavitation on lipid profile in type two diabetic patient with abdominal obesity.Type two diabetic patients with abdominal obesity , randomly assigned into 3 equal groups: 66 patients

  • study group (A) 22 patients : They will receive ultrasound cavitation , HIIT and diatery advice .
  • study group (B) 22 patients : They will receive HIIT and diatery advice .
  • control group 22 patients They will only receive diatery advice.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient with type 2 diabetes.
  • waist circumference >102 cm in male ,>88 cm in female
  • lipid profile range will be (between border line and high risk ).

Exclusion criteria

Kidney disease Heart disease Lung disease ,Liver disease ,Neurological disorders ,Pregnant women , breast feeding, immune deficiency , cancer Heavy smoker

Exclusion criteria

-

Treatment and study plan

Cavitation : Study group A only will receive one session per week for three months (total 12 sessions ). Ultrasound treatments are performed using an applicator head with diameter 7 cm . Intensity :

Device

Cavitation :

Study group A only will receive one session per week for three months (total 12 sessions ).

Ultrasound treatments are performed using an applicator head with diameter 7 cm .

Intensity : 0.1-0.5 w/cm2 (low) Frequency : 30-40 KHZ (low) Duration : 30 minutes

high intenisty exercise

Other

type: alternate high intensity exercise (aerobic or strength training) with recovery stages Intensity: high intensity (75%-95% HRmax) or RPE(14-16 hard to very hard ) ( according to patient tolerance), followed by active or passive recovery stage (30%-60% HRmax) or RPE(7-11 extremely light to light) .

frequency : 3 days per week for three months (with no more than 2 consecutive days between sessions) Duration: 10 seconds to 4 minutes high intensity ,12 seconds to 5 minutes active or passive recovery .(according to patient tolerance) 5 minutes warm up pre exercise . 5 minutes cool down post exercise . Progress gradually. total duration :20-40 minutes (according to patient tolerance and progression)

Diet

Dietary Supplement

In all groups (both study groups A&B and control group).

Primary outcomes

  1. Anthropometric Measurements

    Time frame: 3 months

    It will be performed before and after the treatment . Weight in (kg) is measured by in body scale During the measurement of height in( cm) patient is barefoot . Body mass index (BMI): weight (kg)/ [ height (m)] 2

  2. Lipid profile

    Time frame: 3 months

    contains (cholesterol, triglycerides, Low-density lipoprotein cholesterol (LDL), and high-density lipoprotein cholesterol (HDL)).

Study contacts

Contact information is provided by the study sponsor or research team.

Mahmoud awd elkholy, lecturer of physical therapy

CONTACT

[email protected]

00201125746573

Sponsors and collaborators

Lead sponsor

Mahmoud Awad Ramadan Elkholy

Other

Registry information

Official study title

Combined Effect of High Intensity Interval Training and Ultrasound Cavitation on Lipid Profile in Type 2 Diabetes Patients With Abdominal Obesity

Acronym: Diabeties

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 15, 2025
Registry last updated
Apr 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.